BioCryst Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Key Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. META
5. MU
6. ACN
7. NVDA
8. BLZE
9. IBM
10. PRIM

Go back to BioCryst Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Key Milestones

BioCryst Pharma (BCRX) Misses Q4 EPS by 23c

February 21, 2023 7:06 AM EST

BioCryst Pharma (NASDAQ: BCRX) reported Q4 EPS of ($0.40), $0.23 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $79.5 million versus the consensus estimate of $75.57 million.

For earnings history and earnings-related data on BioCryst Pharma (BCRX) click here.

... More